Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
NCT03745339 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-05-22
Summary
Background:
People with addictions often find it hard to choose the long-term benefits of abstinence over the short-term effects of using drugs. Researchers think this is partly due to parts of the brain involved in certain types of learning and decision-making. Researchers want to test these basic functions using a simple task with pictures and odors.
Objective:
To see if performance in a learning task differs between people who have opioid-use disorder and people who don t.
Eligibility:
Adults 21-60 years old who are willing to fast for at least 6 hours and smell food odors. Those with an opioid-use disorder must either not use for at least 3 weeks or be in treatment.
Design:
Participants will have 1 visit that will take up to 5 hours.
Before the visit, participants will be asked to not eat or drink anything except water for at least 6 hours.
At the visit, participants will be checked for signs of intoxication.
Participants will give urine and breath samples.
Participants will have tests of learning and behavior. They will look at shapes on a computer screen. The shapes will be paired with different food odors.
The odors will come from a sterile tube placed under the nose.
Participants will have their breathing monitored with a belt around the upper abdomen.
About 30 days and 60 days later, participants will be called and asked about their drug use over the past 30 days.
...
Conditions
- Opioid-Related Disorders
- Drug Addiction
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Thorsten Kahnt, Ph.D. · National Institute on Drug Abuse (NIDA)
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-06-07
- Primary Completion
- 2026-10-01
- Completion
- 2026-10-01
Countries
- United States
Study Locations
More Related Trials
-
Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)
NCT01030835 ·Status: COMPLETED
-
Effects of Repeated Memory Training on Memory Function and Addiction Related Processes
NCT03285256 ·Status: TERMINATED ·Phase: NA
-
Working Memory Training for Substance Dependent Individuals
NCT02119949 ·Status: COMPLETED ·Phase: NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
NCT06434818 ·Status: RECRUITING ·Phase: PHASE2
-
fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults
NCT01320748 ·Status: COMPLETED ·Phase: NA
-
Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study
NCT02107352 ·Status: COMPLETED
-
Oxytocin and Stress Response in Alcohol Use Disorder
NCT03610633 ·Status: COMPLETED ·Phase: PHASE2
-
Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation
NCT02639273 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder
NCT05093296 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.
NCT02068261 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge
NCT01969617 ·Status: COMPLETED ·Phase: PHASE1
-
Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
NCT03878316 ·Status: COMPLETED ·Phase: PHASE2
-
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
NCT04971681 ·Status: TERMINATED ·Phase: NA
-
Neurobiology of Alcohol and Nicotine Co-Addiction
NCT03338933 ·Status: COMPLETED
-
Oxytocin Treatment of Alcohol Dependence
NCT02251912 ·Status: COMPLETED ·Phase: PHASE2
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence
NCT02382276 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin in Alcohol Use Disorder
NCT02711189 ·Status: WITHDRAWN ·Phase: PHASE1
-
Neurofeedback Training for the Treatment of Substance Use Disorders
NCT03356210 ·Status: COMPLETED ·Phase: NA
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin Treatment for Alcohol Use Disorders
NCT03636555 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cognitive Dysfunction in the Addictions Study - Project 4 (P4)
NCT06299787 ·Status: RECRUITING ·Phase: NA
-
Cerebellar Involvement in Alcohol Use Disorder (AUD)
NCT05732207 ·Status: RECRUITING ·Phase: NA
-
Cognitive Rehabilitation for Opioid Abuse-related Cognitive Impairment
NCT04404348 ·Status: SUSPENDED ·Phase: NA